CS
BIAF icon

Clear Street’s bioAffinity Technologies BIAF Stock Holding History

Clear Street’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3
Closed -$208 – 598
2024
Q3 		$208 Buy
+3
New +$180 ﹤0.01% 656
2024
Q2 		– Sell
-3
Closed -$202 – 817
2024
Q1 		$202 Buy
+3
New +$157 ﹤0.01% 716

Other funds holding BIAF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Clear Street's BIAF Position: Q4 2024 in Review

Clear Street sold out of bioAffinity Technologies (BIAF) in Q4 2024, closing a stake of 3 shares — an estimated $208 sold.

Clear Street first reported a position in BIAF in Q1 2024 and held it in 2 quarters. The position peaked at $208 in Q3 2024. 16 funds tracked by Wall St. Rank hold BIAF as of Q4 2024.

  • Clear Street reported no remaining bioAffinity Technologies position as of Q4 2024 after selling out during the quarter.
  • Clear Street sold 3 bioAffinity Technologies shares in Q4 2024, an estimated $208.
  • Clear Street first reported a position in bioAffinity Technologies in Q1 2024 and held it in 2 quarters.
  • Clear Street's bioAffinity Technologies position peaked at $208 in Q3 2024.
  • 16 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q4 2024.

Based on Clear Street's 13F filing for Q4 2024, filed 14 Feb 2025.